Home 2021-04-21T08:54:27+00:00

 

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and education in the life sciences, biotechnologies, and pharmaceutical fields. Its main focus is drug development for small populations (paediatric and rare diseases).

Mission
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) mission is to perform innovative research initiatives in the European scenario and in particular to enhance paediatric research from drug discovery and early development to medicines formulations and clinical phases.
CVBF promotes networking within the scientific community and collaboration between stakeholders with an ethical patient-centred approach.
CVBF supports adequate policies pushing towards higher scientific, regulatory, ethical and societal standards for a better implementation of health systems and allocation of resources. CVBF activities are organised within two organisational areas Development&Networking and Clinical Research.

CVBF Brochure

On-going Projects

Latest News

1005, 2021

DEEP-2 Study results published on EU and US CTs registries

The results of the DEEP-2 paediatric clinical trial are now available on ClinicalTrials.org as well as on the EU Clinical Trials Register. DEEP-2 is a multi-centre, randomised, open-label, non-inferiority active-controlled efficacy-safety trial involving paediatric patients from [...]

405, 2021

DEEP PROJECT ARTICLE ON BMC MEDICAL ETHICS

On 29 April 2021 the BMC Medical Ethics published the article "Ethical and procedural issues for applying researcher-driven multi-national paediatric clinical trials in and outside the European Union: the challenging experience of the DEEP project" written [...]